Delirium, Dementia, Amnestic, Cognitive Disorders  >>  mavoglurant (STP7)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mavoglurant (STP7) / STALICLA
NCT01019473 / 2009-011743-39: Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea

Terminated
2
44
Europe
AFQ056, Placebo
Novartis Pharmaceuticals
Huntington's Disease, Chorea
08/11
 

Download Options